NCT01713504已完成不适用
Identification of New Markers in the Hypereosinophilic Syndrome
University Hospital, Lille2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2010年6月29日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 41
- 试验地点
- 2
- 主要终点
- The aim is to characterize, through an approach immunoprotéomique, new HES biomarkers more informative and easier access than those currently available to us. These biomarkers will help to the diagnosis of HES, compared with other causes of eosinophilia.
研究概览
简要总结
The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •dated and signed informed consent
- •virale serology negative or negative result less than 6 months
- •virale serology negative for HBV or vaccinated patient
- •virale serology negative or negative result less than 6 months
- •negative pregnancy test or female menopause for at least 1 year
排除标准
- •subject enable adult, under guardianship or under protective measures of justice
- •Refusal or inability to give informed consent
- •The hypereosinophilic syndrome explained origin other than than atopy, bullous pemphigoid, the Churg-Strauss syndrome and DRESS
研究组 & 干预措施
Hypereosinophilic syndrome unexplained
Experimental
干预措施: biologie sample (Biological)
Hypereosinophilic syndrome explained
Active Comparator
干预措施: biologie sample (Biological)
Normal rate of eosinophilic
Sham Comparator
干预措施: biologie sample (Biological)
结局指标
主要结局
The aim is to characterize, through an approach immunoprotéomique, new HES biomarkers more informative and easier access than those currently available to us. These biomarkers will help to the diagnosis of HES, compared with other causes of eosinophilia.
时间窗: one month after patient inclusion
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
TrinetX Study of Hypereosinophilic Syndrome (HES) Without an Identifiable Non-haematological Secondary CauseHypereosinophilic Syndrome (HES)NCT06172751AstraZeneca250
已完成
3 期
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)Hypereosinophilic SyndromeHypereosinophiliaNCT00086658GlaxoSmithKline86
Unknown
不适用
New Serological Markers for Eosinophilic EsophagitisEosinophilic EsophagitisNCT01624129Technical University of Munich20
已完成
不适用
Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric PatientsGastroesophageal RefluxEosinophilic EsophagitisNCT03069573Federal University of Uberlandia110
已完成
不适用
Risk Factors and Biomarkers for Diagnosis and Treatment of EoEEosinophilic EsophagitisNCT01988285University of North Carolina, Chapel Hill800